Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00025025 · ClinicalTrials.gov registry record
Screening Tests in Detecting Colorectal Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 4,482
- Enrollment target
NCT00025025 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 4,482 participants.
The verdict
NCT00025025 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 4,482 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for colorectal cancer. PURPOSE: Randomized screening trial to compare the effectiveness of fecal occult blood testing with that of DNA-based testing of stool and blood in identifying colorectal cancer.
Interventions
- OTHER sample testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,482 participants |
| Start Date | 2001-10 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00025025
The ClinicalTrials.gov registry entry for NCT00025025 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,482 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sample testing is the first listed.
NCT00025025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00025025 about?
NCT00025025 is a clinical study titled "Screening Tests in Detecting Colorectal Cancer". RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for colorectal cancer. PURPOSE: Randomized screening trial to compare the effectiveness of fecal occult blood testing with that of DNA-based testing of stool and blood in identifying colorectal c...
What is the current status of trial NCT00025025?
This trial is currently completed. The enrollment target is 4,482 participants. The study started on 2001-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00025025?
The interventions under investigation include: sample testing (OTHER).
Who is sponsoring clinical trial NCT00025025?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.